Clinical and Laboratory Parameters of Mast Cell Activation as Basis for the Formulation of Diagnostic Criteria
The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Mast cell (MC) activation occurs in a number of different pathologic conditions. Acute activation is commonly seen in patients with allergic reactions, with consecutive massive release of vasoactive and proinflammatory mediator substances from MCs, leading to the clinical signs and symptoms of anaphylaxis. In these patients, serum tryptase concentrations usually increase subtantially above baseline levels. Chronic MC activation is more difficult to diagnose, especially when symptoms are mild or atypical, and no underlying disease is found. In these patients, serum tryptase levels usually are normal. In a smaller group of patients, tryptase levels are constantly elevated and may point to an occult form of mastocytosis. These patients have to be examined for MC monoclonality, other criteria of a primary MC disease, non-MC hematopoietic neoplasms, and reactive disorders producing chronic MC activation or MC accumulation. In most patients in whom MC activation is found, histamine-induced symptoms can be documented and usually respond to treatment with histamine receptor antagonists or MC stabilizers. If this is not the case, alternative explanations for symptoms and differential diagnoses have to be considered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
Samuelsson, B. (1983) · Science · doi:10.1126/science.6301011 · Cited by 2,843
Johansson, S. G. O., Bieber, T., Dahl, R., Friedmann, P. S., Lanier, B. Q., Lockey, R. F., Motala, C., Ortega Martell, J. A., Platts-Mills, T. A. E., Ring, J., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.12.591 · Cited by 2,391
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H.-P., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Nuñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,108 · cited 1×
“This antigen (low-affinity IL-2 receptor) is not expressed on normal (resting) MCs, but is usually expressed on neoplastic MCs in SM. Therefore, CD25 expression in MCs has been proposed as a minor diagnostic criterion of SM [”
BackgroundSelf-citationHistamine and histamine intolerance
Maintz, L., & Novak, N. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1185 · Cited by 864
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationIdentification of Profilin as a Novel Pollen Allergen; IgE Autoreactivity in Sensitized Individuals
Valenta, R., Duchêne, M., Pettenburger, K., Sillaber, C., Valent, P., Bettelheim, P., Breitenbach, M., Rumpold, H., Kraft, D., & Scheiner, O. (1991) · Science · doi:10.1126/science.1857985 · Cited by 637 · cited 1×
“In several instances, autoallergens are detected, which points to a relationship to autoimmune disorders [”
BackgroundSelf-citationDiagnostic Value of Tryptase in Anaphylaxis and Mastocytosis
Schwartz, L. B. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.010 · Cited by 477
Bonadonna, P., Perbellini, O., Passalacqua, G., Caruso, B., Colarossi, S., Dal Fior, D., Castellani, L., Bonetto, C., Frattini, F., Dama, A., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.018 · Cited by 392
Schwartz, L. B., Sakai, K., Bradford, T. R., Ren, S., Zweiman, B., Worobec, A. S., & Metcalfe, D. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118337 · Cited by 371 · cited 1×
“A reliable marker in suspected (occult) SM is the basal serum tryptase level. Notably, in most patients with SM, basal tryptase levels are elevated to greater than 20 ng/ml even if skin lesions are not detectable [”
Background
Research works printed but not linked: 2
- 10.1016%2Fj.jaci.2009.12.981 · DOI · Paper page
- 10.1016%2Fj.jaci.2009.12.936 · DOI
Cited by
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile
Calderón, M. A., Simons, F. E. R., Malling, H. ‐., Lockey, R. F., Moingeon, P., & Demoly, P. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02761.x · Cited by 286
“However, the relationship between serum tryptase levels and chronic mast cell activation is subject to debate (42).”
BackgroundProposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
“When MC involvement is documented and the reaction is severe, an MCA syndrome (MCAS) may be diagnosed.(21-28) In the past 50 years, clinical symptoms resulting from MCA have primarily been documented in the context of allergic diseases.”
BackgroundSelf-citationHuman mast cell tryptase in biology and medicine
Vitte, J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.04.001 · Cited by 152
The mastocytosis society survey on mast cell disorders: patient experiences and perceptions
Jennings, S., Russell, N., Jennings, B., Slee, V., Sterling, L., Castells, M., Valent, P., & Akin, C. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2013.09.004 · Cited by 143
“Nearly all respondents noted at least one MCD symptom trigger, and many provoking factors were similar to reports found in the literature.(3,4,6,9,16,21,22) Anaphylaxis rates for specific MCD patient populations may be influenced by sex, age, MCD classification, and the presence of skin lesions(8,10,11,16,18,23) and h…”
ResultSelf-citationPredictors of clinical effectiveness of Hymenoptera venom immunotherapy
Ruëff, F., Vos, B., Oude Elberink, J., Bender, A., Chatelain, R., Dugas‐Breit, S., Horny, H. ‐., Küchenhoff, H., Linhardt, A., Mastnik, S., et al. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12275 · Cited by 139
Self-citationBiomarkers for evaluation of mast cell and basophil activation
Kabashima, K., Nakashima, C., Nonomura, Y., Otsuka, A., Cardamone, C., Parente, R., De Feo, G., & Triggiani, M. (2018) · Immunological Reviews · doi:10.1111/imr.12639 · Cited by 122
Self-citationMast cell activation syndromes: definition and classification
Valent, P. (2013) · Allergy · doi:10.1111/all.12126 · Cited by 120
Self-citationTheoharides, T. C., Tsilioni, I., & Ren, H. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1596800 · Cited by 120
Valent, P., Hartmann, K., Bonadonna, P., Gülen, T., Brockow, K., Alvarez-Twose, I., Hermine, O., Niedoszytko, M., Carter, M. C., Hoermann, G., et al. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.05.007 · Cited by 90
Self-citationMast cell activation syndromes: Collegium Internationale Allergologicum update 2022
Valent, P., Hartmann, K., Bonadonna, P., Niedoszytko, M., Triggiani, M., Arock, M., & Brockow, K. (2022) · International Archives of Allergy and Immunology · doi:10.1159/000524532 · Cited by 55
Self-citationSpectrum of mast cell activation disorders
Petra, A. I., Panagiotidou, S., Stewart, J. M., Conti, P., & Theoharides, T. C. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.906302 · Cited by 54
“The D816V mutation is also expressed in people in whom neither criteria for SM nor for cutaneous mastocytosis (CM) are fulfilled [22,33,49,54–56] and may contribute to the symptoms of MC activation syndrome (MCAS); specifically, in MCAS cases, in which only KIT mutation is presented, they are defined as monoclonal MC…”
BackgroundButterfield, J., & Weiler, C. R. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.02.021 · Cited by 41
Russell, N., Jennings, S., Jennings, B., Slee, V., Sterling, L., Castells, M., Valent, P., & Akin, C. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.07.032 · Cited by 31
Self-citationCho, C., Nguyen, A., Bryant, K. J., O'Neill, S. G., & McNeil, H. P. (2016) · Immunity, Inflammation and Disease · doi:10.1002/iid3.94 · Cited by 30
“Existing biomarkers, histamine and tryptase have been shown to be elevated in this disease, reflecting increased MC load and activity [6].”
BackgroundBidad, K., Nawijn, M. C., van Oosterhout, A. J. M., der Heide, S. V., & Elberink, J. N. G. O. (2014) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21148 · Cited by 29
“However, in patients with severe reactions to Hymenoptera venom, an underlying systemic mastocytosis (SM) is frequently diagnosed (4).”
BackgroundComment, L., Bonetti, L. R., Mangin, P. J., & Palmière, C. (2014) · Forensic Science International · doi:10.1016/j.forsciint.2014.04.006 · Cited by 24
“In living subjects, measurements of histamine and histamine metabolites in plasma and urine may be as accurate as b-tryptase in confirming mast cell activation and serve as diagnostic markers [1,2].”
BackgroundOxidative stress markers are increased in patients with mastocytosis
Gangemi, S., Minciullo, P. L., Magliacane, D., Saitta, S., Loffredo, S., Saija, A., Cristani, M., Marone, G., & Triggiani, M. (2015) · Allergy · doi:10.1111/all.12571 · Cited by 23
Self-citationDisease spectrum in patients with elevated serum tryptase levels
Aberer, E., Savic, S., Bretterklieber, A., Reiter, H., Berghold, A., & Aberer, W. (2015) · Australasian Journal of Dermatology · doi:10.1111/ajd.12146 · Cited by 22
“Increased basal tryptase levels were not only seen in mastocytosis but also in patients with urticaria and angioedema, drug or anaphylactic reactions.(20) Typical further clinical findings that would point to an occult mastocytosis would be severe reactions to hymenoptera stings, unexplained severe osteoporosis, unexp…”
BackgroundSerum Tryptase: A New Biomarker in Patients with Acute Coronary Syndrome?
Pastorello, E. A., Morici, N., Farioli, L., Biase, M. D., Losappio, L. M., Nichelatti, M., Lupica, L., Schroeder, J. W., Stafylaraki, C., & Klugmann, S. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000360164 · Cited by 21
Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease
Afrin, L. B. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000325 · Cited by 20
Gludovacz, E., Schuetzenberger, K., Resch, M., Tillmann, K. E., Petroczi, K., Schosserer, M., Vondra, S., Vakal, S., Klanert, G., Pollheimer, J., et al. (2021) · eLife · doi:10.7554/elife.68542 · Cited by 18
“68542 2 of 21 muscle cells and causes symptoms affecting the cardiovascular system, the skin, and the gastrointestinal and respiratory tracts (Jutel et al., 2009; Valent et al., 2011).”
BackgroundHydroxychloroquine as a novel therapeutic approach in mast cell activation diseases
Espinosa, É., Valitutti, S., Laroche, M., Laurent, C., Apoil, P. A., Hermine, O., Lavit, M., Paul, C. F., & Livideanu, C. B. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.07.004 · Cited by 18
Clonal Mast Cell Activation Syndrome with Anaphylaxis to Sulfites
Cifuentes, L., Ring, J., & Brockow, K. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000348379 · Cited by 17
Akin, C., Siebenhaar, F., Wechsler, J. B., Youngblood, B. A., & Maurer, M. (2024) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2024.03.010 · Cited by 19
Mastocytosis presenting as cardiac emergency
Ridolo, E., Triggiani, M., Montagni, M., Olivieri, E., Ticinesi, A., Nouvenne, A., Magliacane, D., de Crescenzo, G., & Meschi, T. (2013) · Internal and Emergency Medicine · doi:10.1007/s11739-013-1012-0 · Cited by 14
Self-citationFerrara, A. L., Piscitelli, F., Petraroli, A., Parente, R., Galdiero, M. R., Varricchi, G., Marone, G., Triggiani, M., Marzo, V. D., & Loffredo, S. (2019) · Journal of Immunology Research · doi:10.1155/2019/5836476 · Cited by 12
“Detection of tryptase provides information about MC distribution, numbers, proliferation, and activation status [76] and is, therefore, a major marker of mast cell disorders, including mastocytosis [44, 56, 77, 78].”
BackgroundSelf-citationZheng, Q., Xue, Q., Wang, H., Cao, B., Su, Y., Xing, Q., & Yang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.732209 · Cited by 11
“Previous studies have shown that inflammatory mediators associated with degranulation and activation of mast cells and basophils are altered in the plasma/serum of HR patients and can be used as molecular markers for the diagnosis of HR (36, 37).”
BackgroundJaafari‐Ashkavandi, Z., Khademi, B., Akbari, S., & Malekzadeh, M. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.5.2955 · Cited by 10
“It has been shown that serum tryptase may increase in some conditions, including allergic/atopic disorders, some types of leukemia, mastocytosis, Helminth infection, as well as end-stage of kidney diseases (Valent et al., 2011).”
BackgroundMethodResultInfluentialNon‐allergic, mastocytosis‐associated rhinitis
Dollner, R., Taraldsrud, E., Iversen, K. S., Osnes, T., Kristensen, B. W., & Kramer, M. F. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12053 · Cited by 9
Wedman, P., Al-Adhami, A., Beste, M., Edwards, M. K., Chumanevich, A. P., Fuseler, J. W., & Oskeritzian, C. A. (2015) · Microscopy and Microanalysis · doi:10.1017/s1431927615015342 · Cited by 11
Häder, T., Molderings, G. J., Klawonn, F., Conrad, R., Mücke, M., & Sellin, J. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07921-5 · Cited by 8
Management of Anaphylaxis in Pediatric Population
Kuyucu, S., Arıkoğlu, T., & ÖZHAN, A. K. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221021154032 · Cited by 9
Patients with elevated basal tryptase serum levels should be tested for hereditary alpha-tryptasemia
Spoerl, D., Docquier, M., Coattrenec, Y., & Seebach, J. D. (2021) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.220 · Cited by 10
“Thus, TPSAB1 CNV should be tested in cases with elevated basal tryptase levels without obvious explanation such as end-stage kidney disease, helminth infections, and myelodysplastic/myeloproliferative disease (6).”
BackgroundPKC potentiates tyrosine kinase inhibitors STI571 and dasatinib cytotoxic effect.
Tobío, A., Alfonso, A., & Botana, L. M. (2014) · PubMed · Cited by 7
Anaphylaxis attributed to exercise: considerations for sports medicine specialists
Bennett, J. R., Jr. (2015) · The Physician and Sportsmedicine · doi:10.1080/00913847.2015.1000233 · Cited by 10
“In many patients, basal tryptase levels may not be available at the time of the first event but may only be known after complete resolution of symptoms when the test is repeated [68].”
BackgroundCissampelos sympodialis (Menispermaceae): A Novel Phytotherapic Weapon Against Allergic Diseases?
Piuvezam, M. R., Bezerra-Santos, C. R., Bozza, P. T., Bandeira‐Melo, C., Vieira, G. C., & Cost, H. F. (2012) · InTech eBooks · doi:10.5772/25739 · Cited by 6
“Histamine is also of fundamental importance in triggering the allergic symptoms such as swelling (Baroody & Naclerio, 2000), itching (Davidson & Giesler, 2010), bronchospasm (Larsen, 2001) and anaphylactic shock (Valent et al., 2011).”
BackgroundGludovacz, E., Resch, M., Schuetzenberger, K., Petroczi, K., Maresch, D., Hofbauer, S., Jilma, B., Borth, N., & Boehm, T. (2021) · Glycobiology · doi:10.1093/glycob/cwab122 · Cited by 4
Sbeih, N., Bourguiba, R., Hoyeau, N., Launay, J., Callebert, J., Canioni, D., Sokol, H., Hentgen, V., Grateau, G., Hermine, O., et al. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.06.009 · Cited by 3
Briskey, D. R., Ebelt, P., & Rao, A. (2023) · Nutrients · doi:10.3390/nu15234940 · Cited by 4
“An elevation in histamine correlates with the level of mast cell activation and release of proinflammatory mediators [13,14].”
BackgroundRudenko, M. (2022) · EMJ Allergy & Immunology · doi:10.33590/emjallergyimmunol/10144966 · Cited by 1
Stellenwert der In-vitro-Diagnostik nach Anaphylaxie
Vanstreels, L., & Merk, H. F. (2013) · Der Hautarzt · doi:10.1007/s00105-012-2450-8 · Cited by 1
(2015) · Inflammation and Cell Signaling · doi:10.14800/ics.881
Lateef, H. A. E. (2013)
Plasticity of immune system vs. memory therapy IST
Tammaro, A., Romano, I. J., Persechino, F., Parisella, F. R., Trimarchi, I., & Persechino, S. (2017) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2017.01.007
Prise en charge diagnostique et thérapeutique des syndromes d’activation mastocytaire
Clark, E., Schiffmann, A., Jentzer, A., Demoly, P. M., Guilpain, P., & Caimmi, D. P. (2021) · Revue française d'allergologie · doi:10.1016/j.reval.2021.09.002
(2012) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283566807
Ott, H. (2014) · Springer eBooks · doi:10.1007/978-3-642-36999-5_17
Ott, H. (2014) · Springer eBooks · doi:10.1007/978-3-662-44632-4_17
Ott, H., Lange, L., & Kopp, M. (2023) · Springer eBooks · doi:10.1007/978-3-662-62714-3_17
OPTIMIZATION OF THERAPY OF PRUCITIS IN ADULTS
Zaynullina, O. N., Krasil’nikova, E. S., Hismatullina, Z. R., Станиславовна, Г. Е., & Dautova, R. F. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.32751
Metadata
- Authors
- Valent, P., Horny, H.-P., Triggiani, M., & Arock, M.
- Affiliations
- Medical University of Vienna (AT)
- University of Naples Federico II (IT)
- Centre National de la Recherche Scientifique (FR)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2011
- Volume
- 156
- Issue
- 2
- Pages
- 119-127
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2091258962
- Cited by
- 50
- References
- 64
- Citations by year
- 2024: 1 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2015: 5 · 2014: 11 · 2013: 7 · 2012: 3
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- mast cell activation, serum tryptase, anaphylaxis, mastocytosis, antihistamines, mast cell stabilizers, diagnostic criteria, differential diagnosis, monoclonality
- MeSH terms
- Bronchial Provocation Tests, Histamine, Humans, Hypersensitivity, Mast Cells, Mastocytosis, Skin Tests, Tryptases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.